Niceritrol,
Niceritrol Tetrahydrochloride,
Pentaerythritol Tetranicotinate,
Pentaerythritoltetranicotinate,
Perycit,
Tetrahydrochloride, Niceritrol,
Tetranicotinate, Pentaerythritol,
niceritrol,
Perycit,
Pentaerythritol tetranicotinate,
5868-05-3,
Cardiolipol,
Bufor,
SK 1 (Pharmaceutical),
Niceritrolum [INN-Latin],
UNII-F54EHJ34MV,
F54EHJ34MV,
Pentaerithritol tetranicotinate,
Niceritrol [INN:BAN:DCF:JAN],
EINECS 227-519-7,
3-Pyridinecarboxylic acid, 2,2-bis(((3-pyridinylcarbonyl)oxy)methyl)-1,3-propanediyl ester,
BRN 0377170,
NCGC00185747-01,
DSSTox_CID_3364,
NICOTINIC ACID, NEOPENTANETETRAYL ESTER,
DSSTox_RID_76993,
DSSTox_GSID_23364,
C29H24N4O8,
Pentaerythritoltetranicotinate,
[3-(pyridine-3-carbonyloxy)-2,2-bis(pyridine-3-carbonyloxymethyl)propyl] pyridine-3-carboxylate,
CAS-5868-05-3,
Niceritrolum,
Perycit (TN),
Niceritrol (JP17/INN),
SCHEMBL28053,
AC1L1I94,
CHEMBL1697762,
DTXSID1023364,
CHEBI:31903,
ZINC3831199,
Tox21_113126,
MFCD00215982,
Tox21_113126_1,
AN-5672,
NCGC00185747-02,
LS-96598,
N0974,
D01754,
4-22-00-00376 (Beilstein Handbook Reference),
Niceritrol Tetrahydrochloride,
Tetrahydrochloride, Niceritrol,
Tetranicotinate, Pentaerythritol,
CID4476,
nicotinic acid neopentanetetrayl ester,
D009531,